Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Aug 2026 for Idexx Laboratories INC /de, €40k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Andrew Emerson: trading record in brief
All filings by Andrew Emerson on record concern Idexx Laboratories INC /de. Between 7 August 2025 and 20 August 2026, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 24 August 2026, reports an option exercise of €40k in Idexx Laboratories INC /de. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew Emerson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
265 shares@ US$178.260.0001% mcap15.3% of flowCommon StockSEC:0000874716-26-000125:0
86 shares0Common StockSEC:0000874716-26-000125:1
61 shares0Common StockSEC:0000874716-26-000018:0
1,849 shares@ US$141.6084.7% of flowCommon StockSEC:0000874716-25-000129:0
4 of 4 declarations
